The Cambridge biotechnology company Base4, has been developing long read length single molecule sequencing technology to leverage the key advantages of microdroplet systems to deliver high-throughput, low-cost sequence data from unmodified sample molecules. Building on this research Base4 has developed a novel microdroplet manipulation platform that enables the flexible, reprogrammable manipulation of aqueous droplets with volumes ranging from microlitres to sub-femtolitres. This talk will explore the challenges involved in developing this technolgy and the potential applications in medicine and life science, including next-generation DNA sequencing and pharmaceutical discovery workflows.
Barney Balmforth is a Director and Chief Operating Officer at Base4 and has a Masters degree in Physics from Oxford University and a PhD in Quantum Optics from Cambridge University.
Open to all. To book a place please go to https://localevents.theiet.org/60333a
Cambridge, CB2 1PZ
Want to ask a question about this event?